Global Body Fluid Collection And Diagnostics 麻豆原创 Research Report 2024

Publication ID:

PB508246058

Publication Date:

August 7, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Rapid results, cost-effectiveness, and early prognosis of diseases are some of the factors contributing to the growth of the market.
The global Body Fluid Collection And Diagnostics market was valued at US$ 30530 million in 2023 and is anticipated to reach US$ 47040 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Body Fluid Collection And Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Body Fluid Collection And Diagnostics.
Report Scope
The Body Fluid Collection And Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Body Fluid Collection And Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Body Fluid Collection And Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories
Illumina, Inc
Guardant Health
QIAGEN
Johnson & Johnson
Laboratory Corporation of America Holdings
Biocept Inc
F. Hoffmann-La Roche Ltd.
MDxHealth SA.
Segment by Type
Blood
Saliva
Urine
Cerebrospinal Fluid
Segment by Application
Next Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Fluorescence in situ hybridization (FISH)
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Body Fluid Collection And Diagnostics companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Body Fluid Collection And Diagnostics 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood
1.2.3 Saliva
1.2.4 Urine
1.2.5 Cerebrospinal Fluid
1.3 麻豆原创 by Application
1.3.1 Global Body Fluid Collection And Diagnostics 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Next Generation Sequencing (NGS)
1.3.3 Polymerase Chain Reaction (PCR)
1.3.4 Fluorescence in situ hybridization (FISH)
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Body Fluid Collection And Diagnostics 麻豆原创 Perspective (2019-2030)
2.2 Body Fluid Collection And Diagnostics Growth Trends by Region
2.2.1 Global Body Fluid Collection And Diagnostics 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Body Fluid Collection And Diagnostics Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Body Fluid Collection And Diagnostics Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Body Fluid Collection And Diagnostics 麻豆原创 Dynamics
2.3.1 Body Fluid Collection And Diagnostics Industry Trends
2.3.2 Body Fluid Collection And Diagnostics 麻豆原创 Drivers
2.3.3 Body Fluid Collection And Diagnostics 麻豆原创 Challenges
2.3.4 Body Fluid Collection And Diagnostics 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Body Fluid Collection And Diagnostics Players by Revenue
3.1.1 Global Top Body Fluid Collection And Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Body Fluid Collection And Diagnostics Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Body Fluid Collection And Diagnostics 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Body Fluid Collection And Diagnostics Revenue
3.4 Global Body Fluid Collection And Diagnostics 麻豆原创 Concentration Ratio
3.4.1 Global Body Fluid Collection And Diagnostics 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Body Fluid Collection And Diagnostics Revenue in 2023
3.5 Body Fluid Collection And Diagnostics Key Players Head office and Area Served
3.6 Key Players Body Fluid Collection And Diagnostics Product Solution and Service
3.7 Date of Enter into Body Fluid Collection And Diagnostics 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Body Fluid Collection And Diagnostics Breakdown Data by Type
4.1 Global Body Fluid Collection And Diagnostics Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Body Fluid Collection And Diagnostics Forecasted 麻豆原创 Size by Type (2025-2030)
5 Body Fluid Collection And Diagnostics Breakdown Data by Application
5.1 Global Body Fluid Collection And Diagnostics Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Body Fluid Collection And Diagnostics Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Body Fluid Collection And Diagnostics 麻豆原创 Size (2019-2030)
6.2 North America Body Fluid Collection And Diagnostics 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Body Fluid Collection And Diagnostics 麻豆原创 Size by Country (2019-2024)
6.4 North America Body Fluid Collection And Diagnostics 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Body Fluid Collection And Diagnostics 麻豆原创 Size (2019-2030)
7.2 Europe Body Fluid Collection And Diagnostics 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Body Fluid Collection And Diagnostics 麻豆原创 Size by Country (2019-2024)
7.4 Europe Body Fluid Collection And Diagnostics 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Body Fluid Collection And Diagnostics 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Body Fluid Collection And Diagnostics 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Body Fluid Collection And Diagnostics 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Body Fluid Collection And Diagnostics 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Body Fluid Collection And Diagnostics 麻豆原创 Size (2019-2030)
9.2 Latin America Body Fluid Collection And Diagnostics 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Body Fluid Collection And Diagnostics 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Body Fluid Collection And Diagnostics 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Body Fluid Collection And Diagnostics 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Body Fluid Collection And Diagnostics 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Body Fluid Collection And Diagnostics 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Body Fluid Collection And Diagnostics 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Detail
11.1.2 Thermo Fisher Scientific Inc. Business Overview
11.1.3 Thermo Fisher Scientific Inc. Body Fluid Collection And Diagnostics Introduction
11.1.4 Thermo Fisher Scientific Inc. Revenue in Body Fluid Collection And Diagnostics Business (2019-2024)
11.1.5 Thermo Fisher Scientific Inc. Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Body Fluid Collection And Diagnostics Introduction
11.2.4 Bio-Rad Laboratories Revenue in Body Fluid Collection And Diagnostics Business (2019-2024)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Illumina, Inc
11.3.1 Illumina, Inc Company Detail
11.3.2 Illumina, Inc Business Overview
11.3.3 Illumina, Inc Body Fluid Collection And Diagnostics Introduction
11.3.4 Illumina, Inc Revenue in Body Fluid Collection And Diagnostics Business (2019-2024)
11.3.5 Illumina, Inc Recent Development
11.4 Guardant Health
11.4.1 Guardant Health Company Detail
11.4.2 Guardant Health Business Overview
11.4.3 Guardant Health Body Fluid Collection And Diagnostics Introduction
11.4.4 Guardant Health Revenue in Body Fluid Collection And Diagnostics Business (2019-2024)
11.4.5 Guardant Health Recent Development
11.5 QIAGEN
11.5.1 QIAGEN Company Detail
11.5.2 QIAGEN Business Overview
11.5.3 QIAGEN Body Fluid Collection And Diagnostics Introduction
11.5.4 QIAGEN Revenue in Body Fluid Collection And Diagnostics Business (2019-2024)
11.5.5 QIAGEN Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Body Fluid Collection And Diagnostics Introduction
11.6.4 Johnson & Johnson Revenue in Body Fluid Collection And Diagnostics Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 Laboratory Corporation of America Holdings
11.7.1 Laboratory Corporation of America Holdings Company Detail
11.7.2 Laboratory Corporation of America Holdings Business Overview
11.7.3 Laboratory Corporation of America Holdings Body Fluid Collection And Diagnostics Introduction
11.7.4 Laboratory Corporation of America Holdings Revenue in Body Fluid Collection And Diagnostics Business (2019-2024)
11.7.5 Laboratory Corporation of America Holdings Recent Development
11.8 Biocept Inc
11.8.1 Biocept Inc Company Detail
11.8.2 Biocept Inc Business Overview
11.8.3 Biocept Inc Body Fluid Collection And Diagnostics Introduction
11.8.4 Biocept Inc Revenue in Body Fluid Collection And Diagnostics Business (2019-2024)
11.8.5 Biocept Inc Recent Development
11.9 F. Hoffmann-La Roche Ltd.
11.9.1 F. Hoffmann-La Roche Ltd. Company Detail
11.9.2 F. Hoffmann-La Roche Ltd. Business Overview
11.9.3 F. Hoffmann-La Roche Ltd. Body Fluid Collection And Diagnostics Introduction
11.9.4 F. Hoffmann-La Roche Ltd. Revenue in Body Fluid Collection And Diagnostics Business (2019-2024)
11.9.5 F. Hoffmann-La Roche Ltd. Recent Development
11.10 MDxHealth SA.
11.10.1 MDxHealth SA. Company Detail
11.10.2 MDxHealth SA. Business Overview
11.10.3 MDxHealth SA. Body Fluid Collection And Diagnostics Introduction
11.10.4 MDxHealth SA. Revenue in Body Fluid Collection And Diagnostics Business (2019-2024)
11.10.5 MDxHealth SA. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Thermo Fisher Scientific Inc.
Bio-Rad Laboratories
Illumina, Inc
Guardant Health
QIAGEN
Johnson & Johnson
Laboratory Corporation of America Holdings
Biocept Inc
F. Hoffmann-La Roche Ltd.
MDxHealth SA.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.